Measles Outbreak in Bangladesh: Root Cause Analysis Report
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Sprache: | Englisch |
| Veröffentlicht: |
Zenodo
2026
|
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866902132132675584 |
|---|---|
| author | Dr. Qudrat-E-Khuda |
| author_facet | Dr. Qudrat-E-Khuda |
| contents | <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">Bangladesh experienced a catastrophic measles outbreak beginning in March 2026, reversing two decades of progress in its Expanded Programme on Immunization (EPI). As of 16 May 2026, official surveillance recorded 64,096 cases — 56,572 suspected and 7,524 confirmed — and 453 deaths, of whom 82% were children under five. Applying the Simons et al. (Lancet, 2012) under-reporting correction model, true case estimates range from 155,000 to 490,000 and actual deaths from 1,400 to 4,000, reflecting severe surveillance failure at the district and upazila level.</p> <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">This root cause analysis identifies a cascade of policy, administrative, and institutional failures as the primary drivers. Bangladesh's Health, Population and Nutrition Sector Programme (HPNSP), the legal and operational backbone of EPI since 1998, was effectively cancelled by the Yunus interim government in March 2025 without an adequate replacement framework. Concurrently, the established UNICEF-based Direct Procurement Method was abandoned in favour of a split procurement policy — 50% through UNICEF and 50% through open tender — a decision that bypassed WHO prequalification standards and introduced months of bureaucratic delay. Despite formal warnings from UNICEF as early as December 2025, no corrective action was taken. By March 2026, stocks of six vaccine types, including measles-rubella, were fully exhausted — the first national vaccine stockout in the country's history. Vaccination coverage had collapsed from 97% (MR1, 2023) to approximately 59% in 2025.</p> <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">The outbreak response under the successor BNP government was equally deficient: IHR notification to WHO was delayed by three weeks, no national treatment protocol was issued, hospitals lacked triage systems, and the emergency vaccination campaign was stalled by syringe shortages. WHO classified national risk as "high" and warned of cross-border transmission to Myanmar and India.</p> <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">The analysis concludes with recommendations for immediate procurement restoration through UNICEF/GAVI, formulation of the Sixth HPNSP, establishment of an autonomous National Immunization Board, and a real-time district-level surveillance system to prevent recurrence.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20245089 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Measles Outbreak in Bangladesh: Root Cause Analysis Report Dr. Qudrat-E-Khuda <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">Bangladesh experienced a catastrophic measles outbreak beginning in March 2026, reversing two decades of progress in its Expanded Programme on Immunization (EPI). As of 16 May 2026, official surveillance recorded 64,096 cases — 56,572 suspected and 7,524 confirmed — and 453 deaths, of whom 82% were children under five. Applying the Simons et al. (Lancet, 2012) under-reporting correction model, true case estimates range from 155,000 to 490,000 and actual deaths from 1,400 to 4,000, reflecting severe surveillance failure at the district and upazila level.</p> <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">This root cause analysis identifies a cascade of policy, administrative, and institutional failures as the primary drivers. Bangladesh's Health, Population and Nutrition Sector Programme (HPNSP), the legal and operational backbone of EPI since 1998, was effectively cancelled by the Yunus interim government in March 2025 without an adequate replacement framework. Concurrently, the established UNICEF-based Direct Procurement Method was abandoned in favour of a split procurement policy — 50% through UNICEF and 50% through open tender — a decision that bypassed WHO prequalification standards and introduced months of bureaucratic delay. Despite formal warnings from UNICEF as early as December 2025, no corrective action was taken. By March 2026, stocks of six vaccine types, including measles-rubella, were fully exhausted — the first national vaccine stockout in the country's history. Vaccination coverage had collapsed from 97% (MR1, 2023) to approximately 59% in 2025.</p> <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">The outbreak response under the successor BNP government was equally deficient: IHR notification to WHO was delayed by three weeks, no national treatment protocol was issued, hospitals lacked triage systems, and the emergency vaccination campaign was stalled by syringe shortages. WHO classified national risk as "high" and warned of cross-border transmission to Myanmar and India.</p> <p class="font-claude-response-body break-words whitespace-normal leading-[1.7]">The analysis concludes with recommendations for immediate procurement restoration through UNICEF/GAVI, formulation of the Sixth HPNSP, establishment of an autonomous National Immunization Board, and a real-time district-level surveillance system to prevent recurrence.</p> |
| title | Measles Outbreak in Bangladesh: Root Cause Analysis Report |
| url | https://doi.org/10.5281/zenodo.20245089 |